Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms

If you think of a cavity as a little hole that sugar carved in your tooth, you're missing the real story. The culprit is architecture. Streptococcus mutans doesn't just stick to enamel; it builds a living material around itself—an extracellular matrix that turns simple plaque into a fortified city. Klein, Hwang, Santos, Campanella, and their collaborators make the case that this matrix isn't passive glue. It's the engine of virulence. It shapes tiny neighborhoods where acid pools, slows what can get in or out, and gives the whole biofilm surprising mechanical strength. That combination of microecology and mechanics is why these communities persist in a place that should be washed clean dozens of times a day. Three ingredients do most of the work. The first is exopolysaccharide, or EPS, a set of insoluble glucan polymers that become the biofilm's scaffold. The second is extracellular DNA—eDNA—which sounds like debris but acts more like rebar, weaving through the polysaccharides to toughen the structure and change how cells stick. The third is lipoteichoic acid, or LTA, an anionic polymer from Gram-positive cell walls that shows up in the pellicle that coats teeth and can be built into the matrix. EPS dominates the mass and the architecture, but eDNA and LTA interact with those glucans and even add charge, which can slow down molecules trying to diffuse in—chlorhexidine among them—and help trap acids the bacteria produce. Think of it as a custom gel that controls chemistry and force at the same time. How does S. mutans build it? By outsourcing the bricklaying to enzymes that work right on the surface. Its glucosyltransferases and fructosyltransferases—called Gtfs and Ftfs—use sucrose as the raw material and can grab starch breakdown products as acceptors. That way, the exoenzymes don't have to wait for a factory inside the cell; they synthesize glucans in place, on contact. The GtfB enzyme in particular sticks to the salivary pellicle on hydroxyapatite and even to bacterial cell surfaces. As Chen and colleagues showed years ago and Klein's group expanded on, once GtfB is sitting on a surface, it starts polymerizing glucans that trap the next arriving cells. Even more devious, glucan can form on the surfaces of neighbors—S. mutans and other oral species—so those cells get coated in sticky polymer and start acting like new nucleation sites. Microcolonies sprout, then coalesce into a cohesive, surface-hugging biomass. That scaffold doesn't spread evenly. It thickens where it matters most—right at the tooth interface. Imaging in these studies shows a dense basal EPS layer pressed against the saliva-coated mineral, like a carpet pad under a rug. Above that, the network becomes more open. That gradient matters. It creates diffusion barriers exactly where acids can do the most damage and where saliva's buffering struggles to penetrate. Within those pockets, sugars fermented by S. mutans and its acid-making neighbors push the local pH down into the range of 4.5 to 5.5. Not everywhere, just in little zones. Enough to decalcify enamel and select for acid-tolerant species. Once those niches form, the community tilts toward organisms that thrive there, and the matrix keeps them put. If you could zoom in, you'd see why it works. Klein's imaging overlays show GtfB-built glucans on the pellicle interlaced with eDNA, which appears as a punctate green signal woven through the polymer. Field-emission scanning electron micrographs push the resolution further: nanofibrous eDNA threads crisscross wool-like glucan bundles, all anchored to that thick basal layer. It's not random clutter. It's a composite. And it doesn't treat every species the same. Liao and colleagues showed that when eDNA is present, GtfB pumps out more glucan on the salivary hydroxyapatite surface and on S. mutans cells themselves. More S. mutans binds to those eDNA-glucan structures. S. gordonii tells a different story: it sticks better to the pellicle when eDNA is there, but not to GtfB-made glucan whether or not eDNA is included. Same molecules, different adhesion outcomes. That's a selective filter built right into the matrix. Now for the part your dentist can feel: this stuff is tough. Hwang and colleagues measured the mechanics of intact S. mutans biofilms with rheometry and found they behave like viscoelastic solids. The storage modulus—the measure of elastic, spring-like behavior—was around 31,718 pascals, give or take about 3,400. The loss modulus—the viscous, dissipative part—was roughly 3,775 with a 450 pascal spread. In simpler terms, the biofilm is far more solid than goo. And that solidity lives in the EPS. When they digested the matrix with glucanohydrolases—mutanase to clip alpha-1,3 linkages and dextranase to cut alpha-1,6 linkages—each enzyme alone more than halved the storage modulus compared to untreated biofilms. Combine them, and the stiffness dropped by about a factor of three. If you leave the enzymes on long enough—more than five hours—the three-dimensional scaffolding slumped and came apart. You can see that weakness in motion too. In a device that ramped up shear stress, removal followed a two-step path. First, big chunks sloughed off in proportion to the applied force. Then, as you got closer to the surface, resistance climbed and the last layer clung tightly. That tracks with the imaging: a dense, gluey basal EPS pad keeps the film anchored even after the bulk peels away. If you pretreated with dextranase, the detachment curve shifted. More material let go, and sometimes whole swaths ripped free under shear that the untreated film would have shrugged off. That's the EPS again—not just how much there is, but where it sits—controlling whether brushing and flow can win. Where do the non-sugar components come from? eDNA arrives by at least two routes. Some of it is the inevitable byproduct of autolysis—cells bursting open at the right times—but there's also a steady trickle delivered by membrane vesicles. Steinberger and Holden, and later Allesen-Holm and Perry, traced these contributions in other systems; Liao and colleagues brought them into the S. mutans story. LTA, meanwhile, is abundant in that pellicle film and enters the matrix during cell wall remodeling. Classic work by Rölla and Kuramitsu put LTA on the pellicle map; more recent genetics and biochemistry connect it to biofilm function. Diet ties these release pathways to the outside world. Sucrose and starch don't just feed acid production; they switch on the machinery that builds the matrix. Ahn and colleagues showed that the two-component system lytTS responds to carbohydrate availability via the global regulator CcpA, turning up lrgAB—genes tied to controlled autolysis and biofilm formation. Klein's group observed the same theme: in the presence of sucrose and starch, eDNA release jumps, and expression of the gtfB gene rises, arming GtfB for more surface-bound glucan synthesis. Liao's work closes the loop—eDNA in that environment further boosts GtfB's activity and gets woven into the product, creating a stickier, more cohesive network that favors S. mutans settlement. Add to that the microbial chorus of the mouth. In multispecies settings, S. mutans ramps up eDNA and LTA production, and neighbors can add their own polymers to the mix. It's ecological construction, not a solo project. LTA's role may go beyond just being present. On the genetics side, Klein and colleagues point to a Streptococcus mutans homolog of ltaS—the enzyme that builds lipoteichoic acid—and to the dltABCD operon, which modifies teichoic acids and impacts cell surface charge. Disrupting these pathways changes adhesion and cariogenicity. In the pellicle, LTA can stimulate insoluble glucan synthesis, which means it can nudge GtfB's products toward the stickier, diffusion-limiting end of the spectrum and alter how the matrix binds to enamel. eDNA shows its own indispensability from the other side: add DNase and the matrix loses integrity. You can literally unwind the rebar and watch the structure soften. Loop back to the chemistry inside the matrix, and you see why all of this amplifies disease. The EPS-rich network slows diffusion, so acids generated by fermentation pool locally and saliva's buffers arrive late. The same barriers make antimicrobials less effective. Klein's team noted that adding charged components like LTA and eDNA to the EPS can alter how disinfectants such as chlorhexidine penetrate, shifting exposure profiles inside the film. Mechanically, the solid-like behavior, especially in the basal layer, resists normal hydrodynamic stresses in the mouth. Put together, you get a persistent, acid-shaping, drug-dampening material wrapped around aciduric microbes. So what can you do with that knowledge? One straightforward idea is to treat the matrix like a target, not just the microbes. Hwang and colleagues effectively softened biofilms by digesting both alpha-1,3 and alpha-1,6 glucan linkages—using mutanase plus dextranase—cutting stiffness about three-fold and making shear far more effective. That's a strategy: weaken the scaffold, then let brushing and flow do the rest. Another approach is to disrupt the co-factors. DNase stripped out critical strands and reduced cohesion in Klein and Liao's experiments. In principle, molecules that block LTA incorporation or flip the dltABCD charge state could make the matrix more permeable or less adhesive. There's a catch, and it's a practical one. Enzymes have to stay in place long enough to work, and the mouth is a hostile, flushing environment. Clinical retention—keeping the agent where you need it—isn't solved by the bench data. The broader lesson here is elegant in its simplicity. Cariogenic biofilms aren't just bags of bacteria. They're composite materials, built in situ, tuned by diet and by neighbors, and optimized for two jobs: hold on and make acid. As Klein, Hwang, Liao, and collaborators showed, the EPS-eDNA-LTA matrix is the throughline. It creates acidic niches down around pH 4.5 to 5.5, it blocks and filters what can diffuse, and it gives the whole community a storage modulus on the order of thirty thousand pascals—solid enough to survive the daily storm. When you picture plaque now, don't think slime. Think scaffold. And remember that if you want to change the disease, you may need to change the material that makes the disease possible.